Dec 03 2014 Relmada Therapeutics Nominated for Buzz of BIO Contest at the 2015 BIO CEO & Investor Conference View
Dec 02 2014 Relmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study of d-Methadone View
Nov 04 2014 Relmada Therapeutics Appoints Michael Becker As Senior Vice President Of Finance And Corporate Development View
Oct 29 2014 Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of Pain Treatment Drugs View
Oct 16 2014 Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants View
Oct 09 2014 New Report Initiates Coverage on New Public Biopharmaceutical Company, Relmada Therapeutics, Inc. View
Sep 18 2014 Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development View
Sep 16 2014 Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER View
